Centogene N.V.

Company Overview

Centogene is a rare disease diagnostics company. It integrates multiomic technologies (phenomics, genomics, transcriptomics, epigenomics, proteomics, and metabolomics) with its proprietary Centogene Biodatabank and CentoCard-based sample logistics system to provide multidimensional analysis to guide the next generation of precision medicine. The Centogene Biodatabank is a real-world data repository for rare and neurogenerative diseases. It contains over 850,000 patient’ samples from over 120 countries, over 70% of whom are of non-European descent. CentoCard is a sample collection filter card for DNA, RNA, enzymes, and metabolic biomarker extraction.

Financial Highlights (FY 2023)

Company's Business Segments

• Pharmaceutical : This segment provides a variety of products and services to its pharmaceutical partners, including target and drug screening, clinical development, market access, expansion, CENTOGENE Biodatabank Licenses, and Insight Reports.
• Diagnostics : This segment offers targeted genetic sequencing and diagnostic services to patients through its distribution partners and clients, who are typically physicians, labs, and hospitals.